Quick Facts

Also known asCibinetide
CategoryHealing & Recovery
Half-life20 minutes
Routessubcutaneous, intravenous
Common vial sizes2mg, 3mg, 5mg, 10mg
Molecular weight1257 Da
Chain length11 amino acids
SequencepGlu-Glu-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
FDA statusNot approved
Storage2-8°C (refrigerated). Reconstituted: 14 days.

Dosing Protocols

Goal Dose Frequency Route Cycle Notes
Neuropathy Treatment 4 mg 1x/day subcutaneous 4 weeks 4mg daily subcutaneous injection. 28-day cycle.
Tissue Protection 4.5 mg 1x/day subcutaneous 4 weeks 1-8mg daily. 28-day cycle. Dose varies by indication.
Acute Intervention 2 mg 3x/week intravenous Continuous 2mg IV three times weekly. Variable duration. Clinical setting only.
Research Protocol 4 mg 1x/day subcutaneous 4 weeks 4mg daily for 28 days. Standard research protocol.

Protocols shown are for informational purposes only. Consult a healthcare provider before starting any peptide protocol.

Reconstitution Calculator for ARA-290

Pre-filled for ARA-290 2mg vial. Adjust values as needed.

Open Full Calculator

Track Your ARA-290 Protocol

Log doses, manage vial inventory, set injection reminders, and visualize blood concentration levels.

Start Tracking — Free

Common Questions

How do I reconstitute ARA-290?
Add bacteriostatic water to your ARA-290 vial (common sizes: 2mg, 3mg, 5mg, 10mg). The amount of BAC water depends on your desired concentration. Use our reconstitution calculator for exact measurements.
What is the typical dose of ARA-290?
A common dose for ARA-290 is 4 mg 1x/day via subcutaneous. 4mg daily subcutaneous injection. 28-day cycle.
What is the half-life of ARA-290?
The half-life of ARA-290 is approximately 20 minutes. This determines how long the peptide remains active in your body and influences dosing frequency.
How should I store ARA-290?
Store ARA-290 at 2-8°C (refrigerated). Has been evaluated in multiple clinical trials. Lyophilized form recommended for long-term storage. Once reconstituted, use within 14 days.
Is ARA-290 FDA approved?
ARA-290 is not FDA approved and is available for research purposes only. It has not been evaluated by the FDA for safety or efficacy in humans.

References

Related Peptides